Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
α-Synuclein antibody therapy: The case for being aggregate-specific.
Ulf Dettmer
Published: 202510.1016/j.neurot.2025.e00809
No abstract available for this study.